Tsc1 Promotes B Cell Maturation but is Dispensable for Germinal Center Formation

Xinxin Ci,Masayuki Kuraoka,Hongxia Wang,Zachary Carico,Kristen Hopper,Jinwook Shin,Xuming Deng,Yirong Qiu,Shyam Unniraman,Garnett Kelsoe,Xiao-Ping Zhong
DOI: https://doi.org/10.1371/journal.pone.0127527
IF: 3.7
2015-01-01
PLoS ONE
Abstract:Accumulating evidence indicates that the tuberous sclerosis complex 1 (TSC1), a tumor suppressor that acts by inhibiting mTOR signaling, plays an important role in the immune system. We report here that TSC1 differentially regulates mTOR complex 1 (mTORC1) and mTORC2/Akt signaling in B cells. TSC1 deficiency results in the accumulation of transitional-1 (T1) B cells and progressive losses of B cells as they mature beyond the T1 stage. Moreover, TSC1KO mice exhibit a mild defect in the serum antibody responses or rate of Ig class-switch recombination after immunization with a T-cell-dependent antigen. In contrast to a previous report, we demonstrate that both constitutive Peyer's patch germinal centers (GCs) and immunization-induced splenic GCs are unimpaired in TSC1-deficient (TSC1KO) mice and that the ratio of GC B cells to total B cells is comparable in WT and TSC1KO mice. Together, our data demonstrate that TSC1 plays important roles for B cell development, but it is dispensable for GC formation and serum antibody responses.
What problem does this paper attempt to address?